DI SEBASTIANO, PIERLUIGI
 Distribuzione geografica
Continente #
NA - Nord America 3.497
EU - Europa 2.519
AS - Asia 1.315
SA - Sud America 132
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
Totale 7.486
Nazione #
US - Stati Uniti d'America 3.482
SG - Singapore 627
IE - Irlanda 486
IT - Italia 394
CN - Cina 360
UA - Ucraina 333
SE - Svezia 326
DE - Germania 299
GB - Regno Unito 219
TR - Turchia 173
FR - Francia 121
BR - Brasile 119
FI - Finlandia 113
RU - Federazione Russa 89
IN - India 80
AT - Austria 28
BE - Belgio 22
VN - Vietnam 18
NL - Olanda 17
CZ - Repubblica Ceca 15
HK - Hong Kong 13
CA - Canada 10
EU - Europa 7
JP - Giappone 7
ES - Italia 6
GR - Grecia 6
PL - Polonia 6
RO - Romania 6
AR - Argentina 5
BD - Bangladesh 5
EE - Estonia 5
IL - Israele 5
LT - Lituania 5
AU - Australia 4
BG - Bulgaria 4
MO - Macao, regione amministrativa speciale della Cina 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
EC - Ecuador 3
KG - Kirghizistan 3
MA - Marocco 3
PT - Portogallo 3
ZA - Sudafrica 3
CH - Svizzera 2
DK - Danimarca 2
GL - Groenlandia 2
KW - Kuwait 2
LU - Lussemburgo 2
OM - Oman 2
PK - Pakistan 2
RS - Serbia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BT - Bhutan 1
EG - Egitto 1
GA - Gabon 1
HR - Croazia 1
HU - Ungheria 1
IQ - Iraq 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MT - Malta 1
MX - Messico 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PY - Paraguay 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
VE - Venezuela 1
Totale 7.486
Città #
Chandler 842
Dublin 481
Jacksonville 459
Singapore 413
Ashburn 240
Princeton 224
Southend 157
Wilmington 121
Munich 113
Izmir 93
Beijing 88
Santa Clara 86
Nanjing 83
Chieti 82
Dearborn 75
Altamura 72
The Dalles 69
Helsinki 56
Los Angeles 54
Cambridge 51
Washington 49
Ann Arbor 46
Boardman 40
Woodbridge 34
Pescara 30
Moscow 27
New York 25
Brussels 22
Nanchang 22
Vienna 22
Houston 17
Nuremberg 17
Dong Ket 16
Falls Church 16
Shenyang 16
Tianjin 14
Brno 13
Hong Kong 13
Rome 13
Edinburgh 12
Frankfurt am Main 12
Kunming 12
Grevenbroich 11
Vittuone 11
Jiaxing 10
London 10
Pune 10
Amsterdam 9
Hebei 9
Norwalk 9
Boston 8
Hefei 8
Chicago 7
Fairfield 7
San Francisco 7
Seattle 7
São Paulo 7
Ancona 6
Changsha 6
Guangzhou 6
Istanbul 6
Milan 6
Redmond 6
Saint Louis 6
Tokyo 6
Warsaw 6
West Jordan 6
Arcore 5
Bologna 5
Brooklyn 5
Francavilla al Mare 5
Hangzhou 5
Lauterbourg 5
Redwood City 5
Romola 5
Stockholm 5
Toronto 5
Zhengzhou 5
Dallas 4
Düsseldorf 4
Jinan 4
Kocaeli 4
L’Aquila 4
Macao 4
Montreal 4
Ningbo 4
Qingdao 4
Sofia 4
São José dos Campos 4
Turku 4
Athens 3
Augusta 3
Bari 3
Bishkek 3
Camerino 3
Cedar Knolls 3
Council Bluffs 3
Johannesburg 3
Jyväskylä 3
Leawood 3
Totale 4.670
Nome #
Developing a Decision-making Model Based on an Interdisciplinary Oncological Care Group for the Management of Colorectal Cancer 227
High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma 154
Totally laparoscopic complete mesocolon excision for splenic flexure cancer. A single institution experience 118
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 118
MICROSATELLITE ALTERATIONS IN PANCREATIC CARCINOMA 109
Beneficial effects of BB-94, a matrix metalloproteinase inhibitor, in rat experimental colitis 101
Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells 100
[Carcinoma of the male breast. Our experience]. 99
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 98
BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages 98
Batimastat, A Matrix Metalloproyeinase inhibitor accellerates Healing in Rat Experimental Colitis 96
Tumor detectability and conspicuity comparison of standard b1000 and ultrahigh b2000 diffusion-weighted imaging in rectal cancer 96
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 95
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 94
Extracorporeal versus intracorporeal anastomosis after laparoscopic right hemicolectomy: cost-effectiveness analysis 91
[Laparoscopic adrenalectomy: analysis of 65 cases] 91
Totally laparoscopic complete mesocolon excision for splenic flexure cancer 90
Methylation analysis of protocadherin genes in pancreatic adenocarcinoma 87
Full Robotic Distal Pancreatectomy: Safety and Feasibility Analysis of a Multicenter Cohort of 236 Patients 87
Beneficial Effects of Batimastat (bb-94), a Matrix Metalloproteinase Inhibitor, in Rat Experimental Colitis 86
Espressione del Connective Tissue Growth Factor (CTGF) nel cancro pancreatico 83
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer 81
A surgical department for intensified care 80
Influenza dei neurotrasmettitori algogeni sulla crescita cellulare nel cancro del pancreas 79
A modified fast-track program for pancreatic surgery: A prospective single-center experience 79
High Blood Concentration of Leukocyte-Derived Extracellular Vesicles Is Predictive of Favorable Clinical Outcomes in Patients with Pancreatic Cancer: Results from a Multicenter Prospective Study 77
A tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer: Influence on borderline resectable 76
Haemorrhoids and transient receptor potential vanilloid 1 76
MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer 76
Appendicitis: the role of nerves in pain generation 75
Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: A meta-analysis of prospective studies 74
Altered anti-inflammatory response of mononuclear cells to neuropeptide PACAP is associated with deregulation of NF-κB in chronic pancreatitis 74
TRANSFORMING GROWTH FACTOR-BETA PATHWAY IS ACTIVATED IN CHOLECYSTOLITHIASIS 73
Alterations of dna-repeats in pancreatic cancer 73
Endoscopic therapy for type B surgical biliary injury in a patient with short cystic duct. 72
Time-qualified patterns of variation of PPAR γ, DNMT1, and DNMT3B expression in pancreatic cancer cell lines 72
Alterations of dna-repeats in pancreatic cancer 71
Combined therapy in pancreatic cancer 70
Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancreatography: A systematic analysis of benefits and associated risks 70
Determinant-based classification of acute pancreatitis severity: International multidisciplinary classification of acute pancreatitis severity: The 2013 German Edition [Einteilung des Schweregrads der akuten Pankreatitis: Internationale, multidisziplinäre klinische Klassifikation auf Basis pathogenetischer Determinanten: Deutsche Version 2013] 70
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management 70
BAG3 is a novel serum biomarker for pancreatic adenocarcinomas. 69
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients 69
The Pituitary Adenylate Cyclase-Activating Polypeptide Pathway is Activated in Human Chronic Pancreatitis. 68
Growth-associated protein-43 and protein gene-product 9.5 innervation in human pancreas: changes in chronic pancreatitis 68
Interleukin 8 gene expression is increased in patients with chronic pancreatitis (pubbl. su Digestion). 67
Changes in cytokine but not tachynin gene expression in patients with chronic pancreatitis 67
Clock gene expression levels and relationship with clinical and pathological features in colorectal cancer patients 67
Determinant-based classification of acute pancreatitis severity: An international multidisciplinary consultation 67
Mirna expression profiles identify drivers in colorectal and pancreatic cancers 67
Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial 66
Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients 66
Support vector machine based on microRNA expression profiles to predict histological origin of ampullary carcinoma case report of a patient affected from adenocarcinoma of the papilla of vater with lynch syndrome 65
The techniques of duodenum preserving head resection of the pancreas in the treatment of chronic pancreatitis 65
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 65
International Multidisciplinary Classification of Acute Pancreatitis Severity: The 2013 Spanish Edition 65
Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers 65
Mechanism of pain in chronic pancreatitis 64
Expression of interleukin-8 and substance P in human chronic pancreatitis 64
Surgical aspects in management of hepato-pancreatico-biliary tumours in the elderly 64
Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease 64
Pathogenesis of pain in chronic pancreatitis 63
Influence of preoperative biliary drainage on surgical outcome after pancreaticoduodenectomy: Single centre experience 63
Differential expression of connective tissue growth factor in inflammatory bowel disease. 62
Neuroimmune appendicitis: a new pathological entity? 62
The role of extended resection in pancreatic adenocarcinoma: Is there good evidence-based justification? 62
Desmoplastic reaction influences pancreatic cancer growth behavior 61
Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium 61
Correlations among PPARγ, DNMT1, and DNMT3B expression levels and pancreatic cancer 61
How we do it: totally laparoscopic complete mesocolon excision for splenic flexure cancer 60
Cathepsins and pancreatic cancer: The 2012 update. 59
Chronic pancreatitis: The perspective of pain generation by neuroimmune interaction 59
Transforming growth factor-βs and their signaling receptors are coexpressed in Crohn's disease 59
SIRT1 and circadian gene expression in pancreatic ductal adenocarcinoma: Effect of starvation 59
Key Role of Phosphoinositide 3-kinase Class IB in Pancreatic Cancer. 58
Phosphatidylserine receptor in chronic pancreatitis: Evidence for a macrophage independent role 58
Substance P and neprilysin in chronic pancreatitis 58
Changes of protein gene product 9.5 (PGP 9.5) immunoreactive nerves in inflamed appendix 58
The ECM proteoglycan decorin links desmoplasia and inflammation in chronic pancreatitis 58
Chemokine receptor CXCR4: Role in gastrointestinal cancer 57
Borderline resectable pancreatic cancer and the role of neoadjuvant chemoradiotherapy 57
Italian consensus guidelines for chronic pancreatitis 57
Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes 57
Combined modality treatments in pancreatic cancer 56
Genetic variants of membrane metallopeptidase genes in inflammatory bowel diseases 55
Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. 54
Mapping of Phosphoinositide 3-Kinase Pathways in Pancreatic Cancer 54
Phosphoinositide 3-Kinase Class IB plays a key role in human pancreatic cancer 53
Key role of Phosphoinositide 3-Kinase Class IB in pancreatic cancer 53
Neurokinin-2 receptor levels correlate with intensity, frequency, and duration of pain in chronic pancreatitis 53
High blood concentration of circulating cancer stem cell-derived extracellular vesicles is associated with poor survival in advanced colorectal cancer patients 53
MicroRNA co-expression networks exhibit increased complexity in pancreatic ductal compared to Vater's papilla adenocarcinoma 52
Pain and pain generation in pancreatic cancer 52
null 52
The neuroimmune connection in chronic pancreatisis 51
Cronic pancreatitis: evidence for neurogenic inflammation 51
PI3K-gamma upregulation promotes proliferation and AKT activation in pancreatic cancer 50
Nerve Growth Factor and Trk-high affinity receptor(TrkA) gene expression in Inflammatory Bowel Disease 50
Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer 50
Neuroimmune interactions in patients with inflammatory bowel diseases: Disease activity and clinical behavior based on Substance P serum levels 50
Totale 7.226
Categoria #
all - tutte 37.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.605


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020184 0 0 0 0 0 0 0 0 0 0 163 21
2020/2021720 105 14 119 28 65 165 20 18 38 91 16 41
2021/2022595 25 28 16 99 32 10 4 38 36 5 73 229
2022/20232.049 200 312 123 269 143 366 99 183 220 24 76 34
2023/2024904 58 35 81 26 80 300 157 58 1 33 6 69
2024/20251.763 114 349 239 81 68 118 129 140 270 81 174 0
Totale 7.986